XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1

Capital Structure (Tables)

3 Months Ended

Mar. 31, 2022

Stockholders' Equity Note [Abstract]

Schedule of valuation of options granted

Volatility			40%
Risk-free interest rate			1.10% – 1.63%
Dividend yield			0.00%
0% Expected life (years)			10
Forfeiture rate			0.00%

Schedule of option activity under the company's stock option plans

(In thousands, except share and per share data)		Number of Options				Weighted-Average Exercise Price				Aggregate Intrinsic Value
Options outstanding at January 1, 2021			3,133,109			$	3.51			$	—
Granted			1,200,934				12.79
Exercised			(174,223	)			2.51
Forfeited			(276,723	)			3.67
Expired			(4,076	)			2.28
Options outstanding at March 31, 2021			3,879,021			$	6.42			$	—
Options outstanding at January 1, 2022			3,564,289				7.18			$	12,527
Granted			—				—
Exercised			(4,220	)			2.30
Forfeited			(151,641	)			6.85
Expired			(53,425	)			17.73
Options outstanding at March 31, 2022			3,355,003			$	7.03			$	2,445
Options vested and exercisable as of March 31, 2022			2,112,370			$	5.54
Options vested and expected to vest as of March 31, 2022			3,193,314			$	6.90

Schedule of options vested and exercisable

				Options Vested and Exercisable
	Price ($)				Number of Options				Weighted-Average Remaining Contractual Life (Years)				Weighted-Average Exercise Price
$	2.28				842,021				8.14			$	2.28
$	4.86				834,717				8.57			$	4.86
$	7.68-$14.49				435,632				8.82			$	13.12

Schedule of options expected to vest

				Options Vested and Expected to Vest
Price ($)				Number of Options				Weighted-Average Remaining Contractual Life (Years)				Weighted-Average Exercise Price
$	2.28				1,014,500				8.14			$	2.28
$	4.86				1,075,058				8.57			$	4.86
$	7.68-$14.49				1,103,755				8.82			$	13.14

Schedule of company’s warrant activity

		Number of Warrants				Weighted-Average Exercise Price
Warrants outstanding at December 31, 2020			828,171			$	0.02
Granted			377,968				0.02
Exercised			(934,295	)			0.02
Warrants outstanding at March 31, 2021			271,844			$	0.02
Warrants outstanding at December 31, 2021			271,844			$	0.02
Granted			11,467,496				6.02
Exercised			(1,583,288	)			0.00
Warrants outstanding at March 31, 2022			10,156,052			$	6.80

X

- References

No definition available.

+ Details

Name:	agfy_ScheduleOfWarrantActivityTableTextBlock
Namespace Prefix:	agfy_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration